Clinical Features and Laboratory Values Associated with Disease Severity in Covid 19 Patients: A Single Center Experience

Basit Öğe Kaydı
dc.contributor.authorBerber, Nurcan Kırıcı
dc.contributor.authorUlutaş, Özkan
dc.contributor.authorSarıcı, Ahmet
dc.contributor.authorYıldırım, Aslı
dc.contributor.authorÇağaşar, Özlem
dc.contributor.authorGözükara, Harika
dc.contributor.authorBerber, İlhami
dc.date.accessioned2026-06-19T06:24:10Z
dc.date.available2026-06-19T06:24:10Z
dc.date.issued2021
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractBackground: To date, several studies were published about clinical features and laboratory values associated with disease severity in covid 19 patients. We aimed to show the relationship between disease severity and clinical and laboratory characteristics of the patients as a single center experience. Methods: Clinical features and laboratory data of fifty patients diagnosed with Covid-19 by PCR was evaluated at diagnosis. These patients divided into 2 groups as early and advanced disease. Clinical features and laboratory data were compared in terms of severity of disease. Results: In all patients, the most common accompanying disease was coronary artery disease. Cough and headache were the most common complaints. Laboratory values showed low lymphocyte count and high CRP levels in all patients. Twenty four patients in early stage and 26 patients in advanced stage were compared in terms of clinical features and laboratory values. In advanced stage, it was observed that body weight, number of comorbid diseases, age, CRP, procalcitonin, BUN, GGT, fibrinogen, D-dimer and ferritin levels of patients were higher whereas height, serum total protein, albumin and potassium levels were lower when compered with early stage patients (p <0.05). Conclusions: Our data showed that older age, having cough, increased number of comorbid diseases, CRP, BUN, GGT, fibrinogen, D-dimer and ferritin and decresed serum total protein, albumin, potassium levels at the time of diagnosis in COVID-19 patients were associated with advanced stage disease.
dc.identifier.dergipark794659
dc.identifier.doi10.32322/jhsm.794659
dc.identifier.endpage22
dc.identifier.issn2636-8579
dc.identifier.issue1
dc.identifier.orcid0000-0001-8634-2543
dc.identifier.orcid0000-0002-2155-8340
dc.identifier.orcid0000-0002-5916-0119
dc.identifier.orcid0000-0003-3226-2972
dc.identifier.orcid0000-0002-6995-086X
dc.identifier.orcid0000-0003-1208-4072
dc.identifier.orcid0000-0003-3312-8476
dc.identifier.startpage18
dc.identifier.urihttps://doi.org/10.32322/jhsm.794659
dc.identifier.urihttps://hdl.handle.net/20.500.12899/4371
dc.identifier.volume4
dc.language.isoen
dc.publisherMediHealth Academy Yayıncılık
dc.relation.ispartofJournal of Health Sciences and Medicine
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_DergiPark_20260612
dc.subjectCovid 19
dc.subjectSars-Cov-2 infection
dc.subjectDisease severity
dc.titleClinical Features and Laboratory Values Associated with Disease Severity in Covid 19 Patients: A Single Center Experience
dc.typeArticle

Dosyalar

Koleksiyon

Diğer Yayınlar Koleksiyonu